You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API buprenorphine buccal

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing buprenorphine buccal

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
Alvogen Inc	buprenorphine buccal	47781-471	.ALPHA.-TOCOPHEROL ACETATE
Alvogen Inc	buprenorphine buccal	47781-471	ANHYDROUS CITRIC ACID
Alvogen Inc	buprenorphine buccal	47781-471	CARBOXYMETHYLCELLULOSE SODIUM
Alvogen Inc	buprenorphine buccal	47781-471	FERRIC OXIDE YELLOW
Alvogen Inc	buprenorphine buccal	47781-471	FERROSOFERRIC OXIDE
Alvogen Inc	buprenorphine buccal	47781-471	HYDROXYETHYL CELLULOSE
Alvogen Inc	buprenorphine buccal	47781-471	HYDROXYPROPYL CELLULOSE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for buprenorphine buccal

Excipient focus: .ALPHA.-TOCOPHEROL ACETATE

buprenorphine buccal drug variants containing .ALPHA.-TOCOPHEROL ACETATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing .ALPHA.-TOCOPHEROL ACETATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: ANHYDROUS CITRIC ACID

buprenorphine buccal drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

buprenorphine buccal drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

buprenorphine buccal drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

buprenorphine buccal drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYETHYL CELLULOSE

buprenorphine buccal drug variants containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

buprenorphine buccal drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

buprenorphine buccal drug variants containing METHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PEPPERMINT OIL

buprenorphine buccal drug variants containing PEPPERMINT OIL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing PEPPERMINT OIL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYCARBOPHIL

buprenorphine buccal drug variants containing POLYCARBOPHIL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing POLYCARBOPHIL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

buprenorphine buccal drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

buprenorphine buccal drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SACCHARIN SODIUM

buprenorphine buccal drug variants containing SACCHARIN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing SACCHARIN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

buprenorphine buccal drug variants containing SHELLAC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing SHELLAC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM BENZOATE

buprenorphine buccal drug variants containing SODIUM BENZOATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing SODIUM BENZOATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

buprenorphine buccal drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

buprenorphine buccal drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

buprenorphine buccal drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

buprenorphine buccal drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alvogen Inc	buprenorphine buccal	47781-471
>Company	>Ingredient	>NDC

buprenorphine buccal drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.